Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion type Assertion NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_head.
- NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion wasGeneratedBy ECO_0000203 NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_provenance.
- NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion wasDerivedFrom befree-20150227 NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_provenance.
- NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion SIO_000772 19864236 NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_provenance.
- NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion evidence source_evidence_literature NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_provenance.
- NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620412.RA-luW2S76X6-2Vqih3eSos1TUvtK4TIcdSCNqcGib-hI130_provenance.